MicroRNA-496 – A new, potentially aging-relevant regulator of mTOR. Issue 8 (17th April 2016)

• Record Type: Journal Article
• Authors: Rubie, Claudia; Kölsch, Kathrin; Halajda, Beata; Eichler, Hermann; Wagenpfeil, Stefan; Roemer, Klaus; Glanemann, Matthias
• Is Part Of: Cell cycle. Volume 15:Issue 8(2016)
• Page Start: 1108
• Page End: 1116
• Publication Date: 2016-04-17
• Subjects: gene regulation -- Human aging -- mTOR -- microRNA -- PBMC; Cell cycle -- Periodicals; 571.84377
• DOI: 10.1080/15384101.2016.1158360
• Languages: English
• ISSNs: 1538-4101

Abstract

ABSTRACT: Recent findings strongly support a role for small regulatory RNAs in the regulation of human lifespan yet little information exists about the precise underlying mechanisms. Although extensive studies on model organisms have indicated that reduced activity of the nutrient response pathway, for example as a result of dietary restriction, can extend lifespan through the suppression of the protein kinase mechanistic target of rapamycin (mTOR), it still is subject of debate whether this mechanism is operative in humans as well. Here, we present findings indicating that human microRNA (miR)-496 targets 2 sites within the human mTOR 3′UTR. Coexpression of miR-496 with different fusion transcripts, consisting of the luciferase transcript and either wild-type mTOR 3′UTR or mTOR 3′UTR transcript with the miR-496 binding sites singly or combined mutated, confirmed this prediction and revealed cooperativity between the 2 binding sites. miR-496 reduced the mTOR protein level in HeLa-K cells, and the levels of miR-496 and mTOR protein were inversely correlated in Peripheral Blood Mononuclear Cells (PBMC), with old individuals (n=40) harbouring high levels of miR-496 relative to young individuals (n=40). Together, these findings point to the possibility that miR-496 is involved in the regulation of human aging through the control of mTOR.